Qube Research & Technologies LTD Repare Therapeutics Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.02 - $4.7 $2,050 - $3,191	-679 Reduced 69.43%	299 $0
Q1 2024 May 14, 2024	SELL	$4.53 - $8.41 $9,431 - $17,509	-2,082 Reduced 68.04%	978 $4,000
Q4 2023 Feb 13, 2024	BUY	$3.22 - $11.79 $9,853 - $36,077	3,060 New	3,060 $22,000
Q4 2022 Feb 14, 2023	SELL	$12.5 - $18.13 $19,612 - $28,445	-1,569 Reduced 12.83%	10,664 $156,000
Q3 2022 Nov 14, 2022	SELL	$11.57 - $15.59 $41,605 - $56,061	-3,596 Reduced 22.72%	12,233 $148,000
Q2 2022 Aug 15, 2022	BUY	$8.45 - $14.84 $133,755 - $234,902	15,829 New	15,829 $221,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.